Cannabis Science Inc.
548 Market Street
Suite 16645
San Francisco
California
94104
United States
Tel: 888-889-0888
Fax: 866-943-5085
Email: info@cannabisscience.com
210 articles about Cannabis Science Inc.
-
Cannabis Science Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication to Treat Asthma/COPD Overlap Syndrome and Clinical Trials to Start Soon
11/28/2017
Our new formulary will target four aspects of this illness inflammation, airway constriction, capacity, and anxiety.
-
Cannabis Science Presents Its African Drug Development Initiative At Major U.S.-Africa Policy Conference
9/29/2017
-
Cannabis Science "Nanoparticle Drones To Target Lung Cancer With Radiosensitizers And Cannabinoids" Full Publication Released Today In Frontiers In Oncology
9/21/2017
-
Cannabis Science Announces Publication Of Initial Research Results Using Nanoparticle Drones To Target Lung Cancer With Radiosensitizers And Cannabinoids In The Renowned Journal Frontiers In Oncology
9/18/2017
-
Cannabis Science Announces Publication Of Initial Research Results Using Nanoparticle Drones To Target Lung Cancer With Radiosensitizers And Cannabinoids In The Renowned Journal Frontiers In Oncology
9/14/2017
-
Cannabis Science Announces Participation In Major U.S.-Africa Policy Forum In Washington, DC
9/8/2017
-
Cannabis Science Launches A Global Consortium And Announces Updates On Its Drug Development Initiatives And Research Collaborations
8/23/2017
-
Cannabis Science Releases Its 2017 Guidance Report For 2nd Quarter 2017, And Outlines Company's Performance And Growth Opportunities As The Medical Cannabis Industry Expands Dramatically
7/6/2017
-
Cannabis Science Invests In The Research And Development Of Cannabinoid-Based Medications To Treat COPD And Asthma
6/27/2017
-
Cannabis Science Receives U.S. Federal Government Clearance To Receive U.S. Federal Government Contracts
5/31/2017
-
Cannabis Science Selects Influential Southern California Financial Firm As The Lead To Raise The Proposed 25 Million USD In Expansion Capital And Boost Its Industry Footprint
5/1/2017
-
Cannabis Science 2017 Black Tie Gala For Cannabinoid Research Targeting Critical Ailments, Testimonials, Celebrity Interests, New Partnerships, And Loyalty Gift To Shareholders
4/27/2017
-
Cannabis Science Issues First Quarter Update And Celebrates 4/20 With Unprecedented Revenue Growth Projections And Sustainable Equity Value Looking Forward To More Quarterly Growth And Progress Reports
4/24/2017
-
Cannabis Science Continues Expansions As It Negotiates To Acquire Two Medical Marijuana Dispensaries In Los Angeles, California; The Company Expects To Sign Closing Documents Shortly
4/24/2017
-
Cannabis Science Senior Executives Set To Present Drug Development Initiatives To Key Stakeholders Around The World At The Upcoming Global Health Catalyst Summit At Harvard Medical School Next Week, April 28 - 30th 2017
4/21/2017
-
Cannabis Science To File Offering Memorandum For 25 Million USD In Expansion Capital
4/10/2017
-
Cannabis Science's Acquisition Raises More Questions Than Answers
4/7/2017
-
Cannabis Science To File Offering Memorandum For 25 Million USD In Expansion Capital
4/7/2017
-
CBIS Subsidiary, Cannabis Science Europe Gmbh, Acquires Majority Shares Of German Bio Med Gmbh Jinvator To Facilitate European Expansions, New Products, And Additional Clinical Studies
4/5/2017
-
Protext Mobility Announces Acquisition Of Cannabis Science
3/29/2017